i.v. fluid manufacturing unit
Why Choose Us
- More than 45 years of experience
- Managed by expert industrial consultants
- ISO 9001-2015 Certified
- Registered under MSME, UAM No: DL01E0012000
How We Work
- 24/5 Research Support Get your queries resolved from an industry expert. Ask before you purchase.
- Custom Research Service Speak to our consultants to design an exclusive study for your needs.
- Quality Assurance All reports are prepared by qualified consultants & verified by experts.
- Information Security Your personal & confidential information is always safe and secure.
Product Description
Industry Overview
Intravenous fluids, also known as intravenous solutions, are sterile supplemental fluids administered directly into the bloodstream to restore or maintain fluid volume and electrolyte balance when oral fluid intake is not possible or sufficient. Common IV fluids include sodium chloride solutions, glucose or dextrose solutions, Ringer’s and lactated Ringer’s solutions, electrolyte formulations, and water for injection. These solutions are widely used in hospitals and clinical settings for hydration, fluid volume replacement, correction of electrolyte imbalances, medication delivery, and blood transfusion support.
IV therapy provides a rapid route for delivering fluids and medicines because substances enter the circulation directly. Proper administration requires controlled infusion rates and appropriate handling of IV bags, tubing, drip chambers, roller clamps, slide clamps, and injection ports. Manufacturing IV fluids therefore requires controlled preparation of water and solutions, filtration, filling, sterilization, packaging, and quality control. The report covers standard IV and electrolyte formulations, crystalloid and colloid solutions, Indian Pharmacopoeia specifications, raw materials, Form Fill Seal (FFS) and Blow Fill Seal (BFS) technologies, manufacturing processes, machinery, plant location considerations, suppliers, implementation schedules, and project economics.
Cost Estimation
| Cost Parameter | Value |
|---|---|
| Plant Capacity | 91200 Nos/Day |
| Land & Building (4000 sq.mt.) | Rs. 4.15 Cr |
| Plant & Machinery | Rs. 6.69 Cr |
| Working Capital for 1 Month | Rs. 2.60 Cr |
| Total Capital Investment | Rs. 14.14 Cr |
| Rate of Return | 37% |
| Break Even Point | 52% |
Content Index
- INTRODUCTION
- STANDARD IV & ELECTROLITES
- THE AIMS OF IV FLUID ADMINISTRATION SHOULD BE TO
- BASIC IV SETUP
- LET'S TAKE A LOOK AT THE MOST BASIC POSSIBLE SETUP FOR AN IV:
- LOCATION- TENGNOUPAL DISTRICT
- PLANT PROPOSED PLANT LOCATION:-
- MAP
- CLIMATE
- TRANSPORTATION
- BY AIR:
- BY TRAIN:
- BY ROAD:
- DETAILS OF REGISTRATION
- TYPES OF IV FLUIDS
- IV SOLUTIONS CAN ALSO BE CLASSIFIED BASED ON THEIR PURPOSE:
- CRYSTALLOIDS
- GENERAL CHARACTERISTICS OF CRYSTALLOID
- ISOTONIC IV FLUIDS
- 0.9% NACL (NORMAL SALINE SOLUTION, NSS)
- DEXTROSE 5% IN WATER (D5W)
- LACTATED RINGER’S 5% DEXTROSE IN WATER (D5LRS)
- RINGER’S SOLUTION
- HYPOTONIC IV FLUIDS
- 0.45% SODIUM CHLORIDE (0.45% NACL)
- 0.33% SODIUM CHLORIDE (0.33% NACL)
- 0.225% SODIUM CHLORIDE (0.225% NACL)
- 2.5% DEXTROSE IN WATER (D2.5W)
- HYPERTONIC IV FLUIDS
- HYPERTONIC DEXTROSE SOLUTIONS
- DEXTROSE 10% IN WATER (D10W)
- DEXTROSE 20% IN WATER (D20W)
- DEXTROSE 50% IN WATER (D50W)
- NURSING CONSIDERATIONS FOR HYPERTONIC SOLUTIONS
- DARROW’S SOLUTION
- COLLOIDS
- HUMAN ALBUMIN
- DEXTRANS
- LOW-MOLECULAR-WEIGHT DEXTRANS (LMWD)
- HIGH-MOLECULAR-WEIGHT DEXTRANS (HMWD)
- IV FLUID/ELECTROLYTE THERAPY
- NORMAL SALINE
- VOLUME EFFECTS OF NS
- RINGER'S FLUIDS
- ADVANTAGE:
- DEXTROSE SOLUTIONS
- EFFECT OF DEXTROSE IN FLUID:
- VOLUME EFFECTS
- ?5%D
- ? DNS
- 5% DEXTROSE COMPOSITION:
- DEXTROSE SALINE (DNS)
- PHARMACOLOGICAL BASIS
- DEXTROSE WITH HALF STRENGTH SALINE
- 10% DEXTROSE & 25% DEXTROSE
- ISOLYTE G,M,P,E
- PARACETAMOL 10 MG/ML SOLUTION COMPOSITION
- QUALITATIVE AND QUANTITATIVE COMPOSITION
- METRONIDAZOLE IV SOLUTION
- ECONOMIC PROFILE
- MARKET POSITION
- APPLICATION INSIGHTS
- VOLUME INSIGHTS
- INDIA LARGE VOLUME PARENTERAL (LVP) MARKET SHARE INSIGHTS
- BUSINESS JUSTIFICATION
- PRODUCTS
- WHY IV FLUID?
- GLOBAL INTRAVENOUS SOLUTION MARKET: KEY TRENDS
- GLOBAL INTRAVENOUS SOLUTION MARKET: SEGMENTATION
- GLOBAL INTRAVENOUS SOLUTION MARKET: REGIONAL ANALYSIS
- GLOBAL INTRAVENOUS SOLUTION MARKET: COMPETITIVE LANDSCAPE
- MAJOR FIVE IV FLUID MONITORING DEVICES COMPANIES:
- B. BRAUN MELSUNGEN AG
- BAXTER INTERNATIONAL INC.
- BECTON, DICKINSON AND CO.
- FORTIVE CORP
- ICU MEDICAL INC.
- SOURCE OF MACHINES TECHNOLOGY
- USES AND APPLICATION
- SOME GENERAL INTRAVENOUS FLUIDS
- SPECIFICATION OF INDIAN PHARMACOPEIA ON I.V FLUIDS
- DEXTRAN 40 INJECTIONS
- DEXTROSE INJECTION WHEN DETERMINED BY THE FOLLOWING METHOD:-
- DEXTRAN 110 INJECTIONS
- SODIUM CHLORIDE AND DEXTROSE INJECTION
- BASIC RAW MATERIALS
- REQUIREMENTS OF RAW MATERIALS AND SPECIFICATIONS
- WATER FOR INJECTION
- HDPE PHARMA GRADE LAMINATE/ PLASTIC ROLL
- LABELING
- IDENTIFICATION
- HEAVY METALS
- COMPOSITION OF IV FLUID
- COMPOSITION OF COMMON IV FLUID (MEQ/L)
- COMPOSITION OF IV FLUIDS
- COMPOSITION OF COMMERCIAL I.V. FLUID AVAILABLE
- FORM FILL SEAL TECHNOLOGY
- LIST OF MACHINERY IV BAG PRODUCTION FORM FILL AND SEAL MACHINE
- THE PRODUCTION OF I.V. SOLUTION PRODUCTION LINE CONSISTS
- 1. WATER PURIFYING
- 2. DISTILLATION
- 3. SOLUTION FILLING
- 4. STERILIZATION
- 5. PACKING
- A TYPICAL FFS PROCESS WORKS AS FOLLOWS.
- BASIC OF BFS TECHNOLOGY
- BLOW FILL SEAL EQUIPMENT
- BFS MOLDS AND TOOLING
- BFS TRIALS
- PROCESS
- 1. BLOW MOLDING
- 2. FILLING
- 3. SEALING
- BLOW FILL SEAL MACHINES
- BLOW FILL SEAL IS SUITABLE FOR YOUR APPLICATION:
- ASEPTIC PACKAGING
- BLOW FILL SEAL (BFS) AND FORM FILL SEAL (FFS) TECHNOLOGY
- MANUFACTURING PROCESS OF I.V. FLUID
- 1. DISTILLED WATER PREPARATION:-
- 2. SOLUTION PREPARATION:-
- 3. INJECTION BLOW MOULDING
- 4. MOULDING PROCESS
- 5. FILLING PROCESS
- 6. SEALING PROCESS
- 7. MOULD OPENING PROCESS
- FILTRATION AND FILLING:-
- STERILIZATION:-
- QUALITY CONTROL:-
- THE WHOLE PROCESS CONSISTS OF THE FOLLOWING STEPS:-
- PROCESS FLOW DIAGRAM
- FLOW DIAGRAM OF MANUFACTURING OF I.V. FLUIDS
- SUPPLIERS OF RAW MATERIALS
- POTASSIUM PERMANGANATE
- SODIUM CHLORIDE (I.P. GRADE)
- DEXTROSE
- SUPPLIERS OF PLANT AND MACHINERY
- STERILIZING EQUIPMENTS
- PM METER
- LABELING MACHINES
- TANKS
- BOILER
- FILTER PRESS
- LABORATORY EQUIPMENTS
- MIXER
- PLANT LOCATION FACTORS
- PRIMARY FACTORS
- 1. RAW-MATERIAL SUPPLY:
- 2. MARKETS:
- 3. POWER AND FUEL SUPPLY:
- 4. WATER SUPPLY:
- 5. CLIMATE:
- 6. TRANSPORTATION:
- 7. WASTE DISPOSAL:
- 8. LABOR:
- 9. REGULATORY LAWS:
- 10. TAXES:
- 11. SITE CHARACTERISTICS:
- 12. COMMUNITY FACTORS:
- 13. VULNERABILITY TO WARTIME ATTACK:
- 14. FLOOD AND FIRE CONTROL:
- EXPLANATION OF TERMS USED IN THE PROJECT REPORT
- 1. DEPRECIATION:
- 2. FIXED ASSETS:
- 3. WORKING CAPITAL:
- 4. BREAK-EVEN POINT:
- 5. OTHER FIXED EXPENSES:
- 6. MARGIN MONEY:
- 7. TERM LOANS:
- 8. TOTAL LOAD:
- 9. LAND AREA/MAN POWER RATIO:
- PROJECT IMPLEMENTATION SCHEDULES
- INTRODUCTION
- PROJECT HANDLING
- PROJECT SCHEDULING
- PROJECT CONSTRUCTION SCHEDULE
- TIME SCHEDULE
- MACHINERY PHOTOGRAPHS
- MULTIPLE EFFECT WATER DISTILLATION PLANT
- MIXER
- STORAGE VESSEL
- BLOW FILL SEAL MACHINE
- AUTOMATIC BOTTLE LABELLING MACHINES
- RAW MATERIAL SUPPLIER
- SODIUM LACTATE
- NACL
- KCLC ACL2
- PRODUCT PHOTOGRAPHS
Appendix
- APPENDIX – A:
- 01. PLANT ECONOMICS
- 02. LAND & BUILDING
- 03. PLANT AND MACHINERY
- 04. OTHER FIXED ASSESTS
- 05. FIXED CAPITAL
- 06. RAW MATERIAL
- 07. SALARY AND WAGES
- 08. UTILITIES AND OVERHEADS
- 09. TOTAL WORKING CAPITAL
- 10. TOTAL CAPITAL INVESTMENT
- 11. COST OF PRODUCTION
- 12. TURN OVER/ANNUM
- 13. BREAK EVEN POINT
- 14. RESOURCES FOR FINANCE
- 15. INSTALMENT PAYABLE IN 5 YEARS
- 16. DEPRECIATION CHART FOR 5 YEARS
- 17. PROFIT ANALYSIS FOR 5 YEARS
- 18. PROJECTED BALANCE SHEET FOR (5 YEARS)
Frequently Asked Questions
Intravenous fluids are sterile solutions administered directly into the bloodstream to support hydration, fluid balance, electrolyte management, or medication delivery. Common formulations include sodium chloride, dextrose, Ringer’s solution, lactated Ringer’s solution, and other electrolyte solutions. They are used when oral fluid intake is inadequate or unsuitable and are particularly important in hospitals, surgical care, emergency treatment, and other clinical settings.
The main types of IV fluids include crystalloids and colloids, with crystalloids commonly classified as isotonic, hypotonic, or hypertonic solutions. Examples covered in the report include normal saline, dextrose solutions, Ringer’s fluids, lactated solutions, and electrolyte preparations. Colloids include products such as human albumin and dextrans. Selection depends on the clinical purpose, required fluid or electrolyte replacement, patient condition, and applicable medical protocols.
IV fluids are manufactured through controlled preparation, purification, formulation, filling, sterilization, packaging, and quality-control operations. The report identifies water purification, distillation, solution filling, sterilization, and packing as the five main phases of the production line. Depending on the packaging system, Form Fill Seal (FFS) or Blow Fill Seal (BFS) technology may be used. Strict process controls are required to maintain sterility, composition, container integrity, and product quality.
Form Fill Seal technology is an automated packaging method that forms a container from packaging material, fills it with the product, and seals it within an integrated production process. For IV fluids, FFS systems can support efficient bag production and filling while reducing manual handling. The technology requires suitable machinery, packaging materials, controlled filling operations, sealing systems, and quality checks to maintain package integrity and product safety.
Blow Fill Seal technology is an automated process in which a plastic container is formed, filled, and sealed as part of an integrated manufacturing cycle. The report describes the principal BFS stages as blow molding, filling, and sealing. BFS can be used for pharmaceutical liquid packaging where controlled production and reduced exposure to external contamination are important. Equipment selection depends on the product, container design, production requirements, and applicable quality and regulatory standards.
Key raw materials for IV fluid manufacturing include pharmaceutical-grade water and active ingredients such as sodium chloride and dextrose, depending on the formulation. The report specifically includes Water for Injection, sodium chloride (I.P. grade), dextrose, potassium permanganate, HDPE pharma-grade laminate or plastic roll, and other formulation-specific materials. Raw materials must meet the required pharmaceutical specifications and undergo appropriate identification and quality testing before use in production.
IV fluid manufacturing plants use equipment for water treatment, formulation, filling, sterilization, packaging, and quality control. Equipment identified in the report includes a multiple effect water distillation plant, mixer, storage vessel, Blow Fill Seal machine, automatic bottle labelling machines, sterilizing equipment, PM meter, tanks, boiler, filter press, and laboratory equipment. The precise equipment configuration depends on the selected products, packaging technology, production process, capacity, and required pharmaceutical quality standards.
